SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Julien Paccou, Daniel Wendling, Actualités du traitement du rhumatisme psoriasique : résultats d’une analyse systématique de la littérature réalisée pour les recommandations de la Société française de rhumatologie pour la prise en charge des spondyloarthrites, Revue du Rhumatisme, 2014,

    CrossRef

  2. 2
    Anna R Moverley, Laura C Coates, Philip S Helliwell, Aiming for remission in psoriatic arthritis, International Journal of Clinical Rheumatology, 2014, 9, 2, 147

    CrossRef

  3. 3
    Julien Paccou, Daniel Wendling, Current treatment of psoriatic arthritis: Update based on a systematic literature review to establish French Society for Rheumatology (SFR) recommendations for managing spondyloarthritis, Joint Bone Spine, 2014,

    CrossRef

  4. 4
    Fausto Salaffi, Alessandro Ciapetti, Marina Carotti, Stefania Gasparini, Marwin Gutierrez, Disease Activity in Psoriatic Arthritis: Comparison of the Discriminative Capacity and Construct Validity of Six Composite Indices in a Real World, BioMed Research International, 2014, 2014, 1

    CrossRef

  5. 5
    P. J. Mease, R. Fleischmann, A. A. Deodhar, J. Wollenhaupt, M. Khraishi, D. Kielar, F. Woltering, C. Stach, B. Hoepken, T. Arledge, D. van der Heijde, Effect of certolizumab pegol on signs and symptoms in patients with psoriatic arthritis: 24-week results of a Phase 3 double-blind randomised placebo-controlled study (RAPID-PsA), Annals of the Rheumatic Diseases, 2014, 73, 1, 48

    CrossRef

  6. 6
    Luisa Costa, Francesco Caso, Mariangela Atteno, Antonio Del Puente, Md Abud Darda, Paolo Caso, Augusta Ortolan, Ugo Fiocco, Roberta Ramonda, Leonardo Punzi, Raffaele Scarpa, Impact of 24-month treatment with etanercept, adalimumab, or methotrexate on metabolic syndrome components in a cohort of 210 psoriatic arthritis patients, Clinical Rheumatology, 2014, 33, 6, 833

    CrossRef

  7. 7
    William Tillett, Ade Adebajo, Mel Brooke, Willemina Campbell, Laura C. Coates, Oliver FitzGerald, Laure Gossec, Philip Helliwell, Sarah Hewlett, Jana James, Patricia Minnock, Aisling Reast, Dennis O’Sullivan, Maarten de Wit, Neil McHugh, Patient Involvement in Outcome Measures for Psoriatic Arthritis, Current Rheumatology Reports, 2014, 16, 5

    CrossRef

  8. 8
    Lihi Eder, Dafna D Gladman, Predictors for clinical outcome in psoriatic arthritis – what have we learned from cohort studies?, Expert Review of Clinical Immunology, 2014, 10, 6, 763

    CrossRef

  9. 9
    Barry J Sheane, Vinod Chandran, The future of treatment for psoriatic arthritis, International Journal of Clinical Rheumatology, 2014, 9, 1, 59

    CrossRef

  10. 10
    J. S. Smolen, J. Braun, M. Dougados, P. Emery, O. FitzGerald, P. Helliwell, A. Kavanaugh, T. K. Kvien, R. Landewe, T. Luger, P. Mease, I. Olivieri, J. Reveille, C. Ritchlin, M. Rudwaleit, M. Schoels, J. Sieper, M. d. Wit, X. Baraliakos, N. Betteridge, R. Burgos-Vargas, E. Collantes-Estevez, A. Deodhar, D. Elewaut, L. Gossec, M. Jongkees, M. Maccarone, K. Redlich, F. van den Bosch, J. C.-C. Wei, K. Winthrop, D. van der Heijde, Treating spondyloarthritis, including ankylosing spondylitis and psoriatic arthritis, to target: recommendations of an international task force, Annals of the Rheumatic Diseases, 2014, 73, 1, 6

    CrossRef

  11. 11
    M. N. D. Di Minno, R. Peluso, S. Iervolino, A. Russolillo, R. Lupoli, R. Scarpa, M. N. D. Di Minno, A. Russolillo, A. Di Minno, G. Tarantino, G. Di Minno, R. Peluso, R. Scarpa, P. O. Rubba, S. Iervolino, Weight loss and achievement of minimal disease activity in patients with psoriatic arthritis starting treatment with tumour necrosis factor   blockers, Annals of the Rheumatic Diseases, 2014, 73, 6, 1157

    CrossRef

  12. 12
    Matteo Nicola Dario di Minno, Rosario Peluso, Salvatore Iervolino, Roberta Lupoli, Anna Russolillo, Raffaele Scarpa, Giovanni di Minno, Obesity and the prediction of minimal disease activity: A prospective study in psoriatic arthritis, Arthritis Care & Research, 2013, 65, 1
  13. 13
    Laura C. Coates, Vinod Chandran, Outcome assessment in psoriatic arthritis, Indian Journal of Rheumatology, 2013, 8, S24

    CrossRef

  14. 14
    Oliver Fitzgerald, Kelley's Textbook of Rheumatology, 2013,

    CrossRef

  15. 15
    Matteo Nicola Dario Di Minno, Rosario Peluso, Salvatore Iervolino, Roberta Lupoli, Anna Russolillo, Giovanni Tarantino, Raffaele Scarpa, Hepatic steatosis, carotid plaques and achieving MDA in psoriatic arthritis patients starting TNF-α blockers treatment: a prospective study, Arthritis Research & Therapy, 2012, 14, 5, R211

    CrossRef

  16. 16
    Priscilla C. H. Wong, Ying-Ying Leung, Edmund K. Li, Lai-Shan Tam, Measuring Disease Activity in Psoriatic Arthritis, International Journal of Rheumatology, 2012, 2012, 1

    CrossRef

  17. 17
    Philip J. Mease, Measures of psoriatic arthritis: Tender and Swollen Joint Assessment, Psoriasis Area and Severity Index (PASI), Nail Psoriasis Severity Index (NAPSI), Modified Nail Psoriasis Severity Index (mNAPSI), Mander/Newcastle Enthesitis Index (MEI), Leeds Enthesitis Index (LEI), Spondyloarthritis Research Consortium of Canada (SPARCC), Maastricht Ankylosing Spondylitis Enthesis Score (MASES), Leeds Dactylitis Index (LDI), Patient Global for Psoriatic Arthritis, Dermatology Life Quality Index (DLQI), Psoriatic Arthritis Quality of Life (PsAQOL), Functional Assessment of Chronic Illness Therapy–Fatigue (FACIT-F), Psoriatic Arthritis Response Criteria (PsARC), Psoriatic Arthritis Joint Activity Index (PsAJAI), Disease Activity in Psoriatic Arthritis (DAPSA), and Composite Psoriatic Disease Activity Index (CPDAI), Arthritis Care & Research, 2011, 63, S11
  18. 18
    S. Finzel, M. Englbrecht, Psoriasisarthritis – eine bleibende Herausforderung für Rheumatologen und Patienten, Zeitschrift für Rheumatologie, 2011, 70, 9, 775

    CrossRef